U.S. Life Sciences Stock News

Key recent performance for Semtech (SMTC) With no single headline event in focus, Semtech (SMTC) has still been active on investors’ radar, supported by recent share price moves and the latest reported financial results. The stock shows a 6.4% decline over the past day, while the past month return is about 13% and the past 3 months return is about 23%. Over the past year, the total return is about 150% and the 3 year total return is described as very large. On the fundamentals side, Semtech...

Cavco Industries triggered stock overview Cavco Industries (CVCO) has drawn investor attention after recent share price moves, with the stock up about 15% over the past month while the past 3 months show a modest decline. See our latest analysis for Cavco Industries. While Cavco’s 30 day share price return of 14.5% stands out, year to date share price performance is softer, and the longer term total shareholder returns of 8.5% over 1 year and 154.3% over 5 years show a very different...

Event context and recent share performance Novanta (NOVT) has attracted investor attention after recent share price moves, with the stock closing at US$138.18. The company operates in precision medicine, manufacturing, robotics, automation, and advanced surgery technology. See our latest analysis for Novanta. The recent pullback, with a 1-day share price return of a 1.81% decline to US$138.18, sits against a stronger backdrop, including a 90-day share price return of 20.91% and a 5-year total...

This article examines whether JD.com, at around US$25.64, could be a potential bargain or a value trap by looking closely at what the numbers indicate about the stock. JD.com's share price has recently been under pressure, with declines of 6.8% over 7 days, 10.0% over 30 days, 13.2% year to date, and 35.6%, 40.9% and 68.5% over 1, 3 and 5 years respectively. Recent news flow around JD.com has focused on its position within China's ecommerce sector and on how investor sentiment toward Chinese...

AMETEK (AME) is in focus after reporting Q4 2025 earnings and revenue above forecasts, lifting its 2026 outlook, outlining a $100 million growth investment, and announcing a dividend increase that caught investors’ attention. See our latest analysis for AMETEK. Despite a 2.6% one day share price decline and a flat week, AMETEK’s 5.0% 30 day and 18.1% 90 day share price returns, alongside a 1 year total shareholder return of 29.2%, suggest momentum has recently been building. If this update...

Synopsys stock performance and recent context Synopsys (SNPS) has been under pressure in recent months, with the share price showing a 9% decline over the past month and a similar 9% decline over the past 3 months. Over the past year, Synopsys has recorded a 4.7% negative total return, while revenue of US$8,007.7m and net income of US$1,105.4m sit alongside annual revenue and net income growth figures of 11.9% and 20.3% respectively. See our latest analysis for Synopsys. The recent 7 day...

Core & Main stock: what recent returns say about investor expectations Core & Main (CNM) has drawn fresh attention after a mixed stretch in the share price, with a 1.4% decline over the past day and a 3.5% pullback over the past week. See our latest analysis for Core & Main. Despite the recent pullback, Core & Main’s 90 day share price return of 7.78% and 1 year total shareholder return of 13.64% sit alongside a very large 3 year total shareholder return of about 7x. This suggests that...

GXO Logistics (NYSE:GXO) has entered a new partnership with lingerie retailer Hunkemoller to manage its B2B logistics. The agreement covers operations at a state of the art facility in Almere and is structured as a multi year deal. This is Hunkemoller’s first time outsourcing its B2B logistics operations to an external provider. For you as an investor, this move highlights how GXO Logistics (NYSE:GXO) positions itself as a specialist in complex, tech driven logistics for retailers. The...

If you are wondering whether RLI is offering good value at its recent price, you are not alone. This article will walk through how the current share price stacks up against several valuation checks. RLI shares last closed at US$63.29, with returns of 3.6% over the past week, 8.3% over the past month, 1.3% year to date, a 12.6% decline over the past year, 2.7% over three years, and 37.1% over five years, which gives a mixed picture of recent and longer term performance. Recent headlines...

Agnico Eagle Mines (NYSE:AEM) is back on investors’ radar after a run of strong quarterly earnings beats and rising earnings estimates, which has coincided with solid recent share price gains. See our latest analysis for Agnico Eagle Mines. At a share price of $234.52, Agnico Eagle Mines has seen strong momentum recently, with a 30-day share price return of 23.11% and a year to date share price return of 37.59%. Its 1-year total shareholder return of 147.14% and very large 3-year and 5-year...

NextDecade (NasdaqCM:NEXT) approved positive final investment decisions on Trains 4 and 5 at its Rio Grande LNG Facility. The company executed multiple long term LNG sale and purchase agreements tied to these additional trains. These steps expand NextDecade's planned LNG production capacity and build out its contracted commercial portfolio. NextDecade focuses on developing LNG export capacity at its Rio Grande LNG Facility, positioning itself as a US Gulf Coast supplier to global buyers...

In February and March 2026, Leidos Holdings completed two fixed-rate senior unsecured note offerings totaling about US$1.40 billion and continued rolling out its Terminal Flight Data Manager system, which went live at Reagan National Airport significantly ahead of the typical schedule. The accelerated implementation of this mission-critical airspace modernization program highlights Leidos’ ability to deliver complex government technology projects efficiently while expanding its fixed-income...

Rumors are circulating that Sanofi is considering a significantly higher acquisition bid for Ocular Therapeutix (NasdaqGM:OCUL). The speculation follows recent regulatory developments that may create new or faster FDA approval routes for the company’s ophthalmology programs. Market attention has increased as investors assess what a larger potential offer and altered commercialization timelines could mean for OCUL’s valuation and future role in eye care. Ocular Therapeutix focuses on...

Kyndryl Holdings, Inc. recently reported a past quarter where revenue grew but missed analyst expectations and EPS fell short, even as it expanded AI, cloud, and security offerings, launched a Cyber Defense Operations Center in India, and advanced healthcare AI collaborations in the UK. These developments highlight Kyndryl’s push into integrated AI, cybersecurity, and digital sustainability services, even as weaker earnings raised questions about how quickly that shift can translate into...

In the past week, insurance software provider Guidewire Software announced a multi-year partnership with Sompo Group to roll out its cloud platform globally, received board approval for a share repurchase program, and prepared to report earnings following a quarter that beat revenue expectations but missed billings estimates. Together, the Sompo collaboration, upcoming earnings release, and new buyback authorization highlight how Guidewire is trying to deepen insurer relationships while...

What recent returns say about Marathon Petroleum stock Recent trading in Marathon Petroleum (MPC) has caught investor attention, with the shares showing positive moves over the past week, month, and past 3 months, as well as on a 1 year and multi year basis. Against that backdrop, it is worth looking at how the company’s current valuation metrics, profitability, and business mix across refining, midstream, and renewable diesel compare with the recent share performance. See our latest analysis...

Alamo Group (ALG) closed out FY 2025 with fourth quarter revenue of US$373.7 million and basic EPS of US$1.29, alongside net income of US$15.5 million. Its trailing twelve month figures show revenue of US$1.6 billion, basic EPS of US$8.64 and net income of US$103.8 million. Over recent quarters, the company has seen quarterly revenue move between US$390.9 million and US$420.0 million, with basic EPS ranging from US$1.29 to US$2.65. This gives investors a clear view of how earnings power has...

Assured Guaranty (AGO) has drawn fresh attention after recent trading left the stock around $86.90, with returns mixed across the past week, month, past 3 months, and longer term performance also varied. See our latest analysis for Assured Guaranty. At around $86.90, Assured Guaranty’s recent pullback and modest 1-month share price return of 2.42% contrast with its stronger 3-year and 5-year total shareholder returns of 58.98% and 116.57%. This suggests that long term sentiment has been more...

Eos Energy Enterprises (EOSE) is back in focus after reporting fourth quarter and full year 2025 results, highlighting higher sales, a smaller quarterly net loss, and new 2026 revenue guidance in the US$300 million to US$400 million range. See our latest analysis for Eos Energy Enterprises. Despite the fresh 2026 revenue guidance and stronger quarterly sales, recent trading has been tough, with a 7 day share price return of negative 47.21% and a 30 day share price return of negative 58.61%...

Earnings trigger renewed focus on Royal Gold Royal Gold (RGLD) has moved back into the spotlight after reporting fourth quarter and full year 2025 results, with fresh financials giving investors new data points to assess the royalty and streaming specialist. For the fourth quarter, the company reported sales of US$373.1 million compared with US$200.49 million a year earlier, and net income of US$93.61 million versus US$107.41 million. Basic and diluted earnings per share from continuing...

Recent share performance and business snapshot Analog Devices (ADI) has attracted investor attention after a strong past 3 months, with the stock up about 22% and roughly 24% higher year to date, despite recent week and month pullbacks. The company reports annual revenue of about US$11.76b and net income of roughly US$2.71b, with recent annual figures indicating double digit growth in both revenue and earnings. See our latest analysis for Analog Devices. At a share price of US$338.99, Analog...

In late February 2026, HP Inc. reported first-quarter revenue of US$14,438 million, up from US$13,504 million a year earlier, while net income slipped to US$545 million and earnings per share edged slightly lower. Alongside reaffirming its full-year earnings guidance and continuing share repurchases under a multi-year buyback program, HP signaled ongoing commitment to capital returns despite modest profit pressure. We’ll now examine how HP’s higher revenue but softer earnings, combined with...

If you are wondering whether Moderna's current share price reflects its true worth, you are not alone. The stock has become a frequent talking point for valuation focused investors. Over the short term, the stock has been mixed, with a 1.4% decline over the last 7 days, a 13.1% gain over the last 30 days, and year to date and 1 year returns of 61.5% and 64.1% respectively, while the 3 year and 5 year returns sit at 64.7% and 61.9% declines. Recent headlines around Moderna have largely...

In late February 2026, Arista Networks reported strong fourth-quarter results and lifted its full-year growth outlook and AI revenue forecast to US$3.25 billion, largely driven by accelerating demand from Cloud and AI customers. This shift means AI-related networking could contribute about 30% of Arista’s total revenue this year, with up to four customers each accounting for more than 10% of sales, underscoring both the scale of demand and the concentration of its client base. With Arista...